and to think that Edison puts us in the Blockbuster drug category with just the one GBM treatment... doesn't include any sales for other potential solid tumor cancers that may be targeted in the basket trial... and current MV is roughly the value of a PRV
I have put a peak sale figure of $1.4 billion on CHM 2101 - see below it would need around 15% market share among the four targeted cancers
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $9.747M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $15.97K | 4.812M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 68 | 52690500 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 102587679 | 31 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| CHM (ASX) Chart |